Curated Video
Weight-loss drug approved to reduce risk of non-fatal heart attacks | Canada Tonight
Health Canada has approved the weight-loss drug Wegovy to reduce the risk of non-fatal heart attacks, drug maker Novo Nordisk says. But how does it work? Dr. Samir Gupta discusses Health Canada's decision.
Curated Video
Obesity Epidemic: A Ticking Time Bomb
The U.S. Is facing a health crisis of epic proportions. A sweeping new study reveals a staggering statistic. Nearly three-quarters of American adults are overweight or obese. The implications are dire, as weight-related diseases threaten to
Curated Video
Obesity Becomes A Health Crisis In The US
Obesity has reached alarming levels in the United States, becoming a major public health crisis. Rising rates of obesity are linked to various chronic diseases, including heart disease, diabetes, and certain cancers, putting a...
Curated Video
Canadian obesity rate doubled during pandemic: study
New research published in Canadian Medical Association Journal found that the obesity rate doubled during the COVID-19 pandemic, something researchers say could be linked to more sedentary behaviour and mental health issues driven by...
Press Association
Wes Streeting and Joe Wicks speak about new animated fitness show
Interviews with Health Secretary Wes Streeting and fitness coach Joe Wicks, as the Body Coach launches a new animated character in a bid to keep children fit over the summer holidays. Mr Wicks' new animated persona talks children through...
Bloomberg
Novo Owner Targets More China Biotech Deals
Novo Holdings CEO Kasim Kutay says China has "really moved up the value chain" in healthcare. "We've seen many others investing in China because of the leap that they're taking from an innovation and technology perspective," Kutay says...
Bloomberg
Novo's Next-Gen Obesity Drug Disappoints in a Trial
Novo Nordisk shares plunged the most since December after another disappointment for the drugmaker's next-generation shot CagriSema. The medicine helped patients with diabetes lose 15.7% of their weight over 68 weeks, compared with 3.1%...
Bloomberg
Novo Nordisk CEO on US Tariffs, Weight-Loss Sales, Supply Chain
Novo Nordisk A/S Chief Executive Officer and President Lars Fruergaard Jorgensen discusses the potential impact of tariffs coming from Donald Trump's administration in the US, demand for weight-loss medication, and supply chain...
Bloomberg
J&J Stock Drops Sharply After Earnings Beat
Johnson & Johnson Chief Financial Office Joseph Wolk says its a "little frustrating" to see its stock drop sharply even after reporting an earnings beat on the top and bottom line. The drug maker says a strong dollar will cut into...
Bloomberg
Novo Set to Scale Up Production & Hiring: Sylvest
Novo Nordisk executive vice president for Commercial Strategy & Corporate Affairs, Camilla Sylvest says the company plans to further scale up its production, supply and employment to drive innovation. Speaking on the sidelines of the...
Curated Video
Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiations
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated between the government and manufacturers. (Scripps News)
Bloomberg
Structure CEO on Obesity Drugs: Oral Pills Are the Solution
Structure Therapeutics CEO Raymond Stevens discusses obesity drugs and the company's expansion plans with Katie Greifeld at the JPMorgan Health-Care Conference in San Francisco.
Bloomberg
GoodRx CEO Sees Endless Opportunities for GLP-1s
GoodRx CEO Wendy Barnes discusses how telepharmacy firms navigate pricing and the outlook for obesity drugs with Katherine Greifeld at the JPMorgan Health-Care Conference in San Francisco.
Bloomberg
Regeneron CSO Yancopoulos on Weight-Loss Drugs, Pipeline
Regeneron co-Chair, President and CSO George Yancopoulos discusses the company's planned weight-loss drugs with Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco.
Bloomberg
Takeda CEO Weber on Drug Pipeline, Geopolitical Risks
Takeda Pharmaceutical CEO Christophe Weber discusses the company's drug pipeline and current geopolitical risks with Katie Greifeld at the JPMorgan Health Care Conference in San Francisco.
Bloomberg
Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing
Eli Lilly & Co. Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by Scorpion Therapeutics. He also says Lilly's experimental weight-loss pill could be approved in early 2026. He speaks...
Bloomberg
David Rubenstein Remembers Jimmy Carter
Carlyle Group co-founder and co-chairman and host of "Peer-to-Peer Conversations" David Rubenstein talks about the rising popularity of weight loss drugs and his interview with Eli Lilly CEO Dave Ricks. He also talks about the legacy of...
Bloomberg
Novo Selloff Is an Overreaction, Barclays' Field Says
Emily Field, Barclays' head of European pharmaceutical research, reacts to the selloff in Novo Nordisk's shares after its experimental obesity shot CagriSema failed to meet expectations. She speaks on "Bloomberg Open Interest."
Bloomberg
Rubenstein on Lilly, New FTC Head, Library of Congress
The Carlyle Group co-founder and Bloomberg Host David Rubenstein previews his next episode of "Peer-to-Peer" Conversations. He'll talk to the Librarian of Congress. He also sat down with the CEO of Eli Lilly and spoke about their...
Bloomberg
Lilly Will Test Obesity Drugs on Addiction, CEO Says
Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines can also be used to treat addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive Officer Dave Ricks said. These medicines can...
Bloomberg
Lilly's Zepbound Beats Wegovy in Weight-Loss Drug Trial
Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S's Wegovy in the first head-to-head trial of the two blockbusters. In the study sponsored by Lilly, those on Zepbound lost an average of about 50...
Curated Video
Biden administration wants Medicare, Medicaid to cover anti-obesity medicines
The Biden administration is proposing to expand coverage of anti-obesity medicines for those with Medicare and Medicaid. (Scripps News)
Press Association
Garvey says children are overweight due to being ‘driven everywhere’
Many Irish children are overweight “because they have to be driven everywhere”, the Green Party deputy leader has said. Roisin Garvey made the comments at the Green Party think-in in Dublin, where she said there was a need to expand the...